Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Moves Mesh Surgical Instrumentation Up To Class II In Final Order

Executive Summary

The US agency has agreed with an earlier assessment by an advisory panel last year to up-classify surgical mesh instrumentation by issuing a Jan. 6 final order to move the instrumentation – used for women undergoing pelvic organ prolapse or female stress incontinence procedures – from class I to class II.

Advertisement

Related Content

FDA Panel Endorses Class II Status for Surgical Mesh Instrumentation

Topics

Advertisement
UsernamePublicRestriction

Register

MT104282

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel